Financials
- Market Capitalization 1.54 B
- Employee 435
- Founded 2005
- CEO N/A
- Website www.xerispharma.com
- Headquarter Illinois, United States
- FIGI BBG012V1MG52
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-79.2
売上高対価格比率
4.13
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2160 | AAPG Ascentage Pharma Group International - American Depository Shar | 16.64 USD | +2.53% | -1.13% | -5.19% | -33.44% | 1.55 B USD | ||
| 2165 | INVA Innoviva, Inc. - Common Stock | 21.35 USD | +1.28% | +0.33% | +1.81% | +19.81% | 1.54 B USD | ||
| 2170 | BCAX Bicara Therapeutics Inc. - Common Stock | 23.26 USD | -0.68% | -5.52% | -13.37% | +61.08% | 1.54 B USD | ||
| 2187 | REPL Replimune Group, Inc. - Common Stock | 15.90 USD | +1.47% | +1.15% | +44.55% | +166.78% | 1.50 B USD |